These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 5319767)

  • 1. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G; Vogel A
    Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of xanthinol nicotinate on the small blood vessels.
    Davis E; Rozov H
    Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of 3-(methyl-hydroxyethylamino)-2 hydroxypropyltheophylline nicotinate on hemodynamics of the systemic and pulmonary circulation in normal subjects and patients with mitral stenosis].
    Filocamo G; Giuffrida G; Basile U; Parrinello A; Bellisario G; Pugliese F
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):Suppl:2121-3. PubMed ID: 5876720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of nicotinate of xanthinol prolongatum on the walking distance of patients with arterial insufficiency of the lower extremities].
    Joos F; Basyn M; Rocher A
    Acta Clin Belg; 1972; 27(5):529-47. PubMed ID: 4669777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
    Bollinger A; Lüthy E
    Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of arterial circulatory disorders with Lioftal].
    Greif S
    Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of citrate nicamétate at high doses in cardiovascular surgery].
    Stankowiak C; Vandecasteele J; Soots G
    Lille Med; 1973 Nov; 18(9):1039-42. PubMed ID: 4211730
    [No Abstract]   [Full Text] [Related]  

  • 10. [The action of xanthinol nicotinate on the peripheral circulation of the aged].
    Chevat H; Steenhouwer B; Hiltenbrand C; Legrand MF; Graux P
    Angeiologie; 1968; 20(2):33-42. PubMed ID: 5682235
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G; Judge TG; Walkey F
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute effect of xanthinol nicotinate on cutaneous and intramuscular temperature in diabetic patients].
    Berezovsky MR; Berstein S; Lopez Morillas AM; Novoa FC; Acuña E; Reitich GE; Gottlieb S
    Prensa Med Argent; 1971 Jul; 58(18):923-31. PubMed ID: 5095397
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C
    Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R; Renda A
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases].
    Chiti E
    Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of intermittent claudication with inositol nicotinate.
    Head A
    Practitioner; 1986 Jan; 230(1411):49-54. PubMed ID: 3513149
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modification of the vascular changes of the ocular fundus by xantinol nicotinate].
    von Grósz I; Födö V
    Med Welt; 1969 Aug; 35():1916-7. PubMed ID: 5809867
    [No Abstract]   [Full Text] [Related]  

  • 19. [Xanthinol-nicotinate (complamine)].
    Cas Lek Cesk; 1968; 107(51):1567-8. PubMed ID: 5700857
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the treatment of hyperlipemia with theophylline nicotinate].
    Ciammaichella A
    Atti Soc Ital Cardiol; 1969 Jan; 2():251-60. PubMed ID: 5406537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.